A Non-Precedential Case Study: Federal Circuit Says District Court Did Not Clearly Err in Holding Dosing Patent Invalid Based on Obviousness and Obviousness Type Double Patenting
Holding: In Boehringer Ingelheim Pharms. Inc. v. Mylan Pharms. Inc., No. 2019-1172 (Fed. Cir. March 16, 2020) (non-precedential), the Federal Circuit…
Popular articles from this firm
